Aspen RxHealth

Aspen RxHealth

Signal active

Organization

Contact Information

Overview

Aspen RxHealth is a service powered by an app-based platform that connects pharmacists with patients in need of enhanced medication services. Its application makes it easy for health plans and providers to connect their patients with an on-demand community of pharmacists who have time and expertise to provide clinical service.

About

Industries

Information Technology, Internet, Apps, Mobile Apps, Health Care

Founded

2018

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Aspen RxHealth headquartered in United States, North America, operates in the Information Technology, Internet, Apps, Mobile Apps, Health Care sector. The company focuses on Information Technology and has secured $2.8B in funding across 80 round(s). With a team of 11-50 employees, Aspen RxHealth is actively contributing to advancements in Information Technology. Their latest funding round, Series B - Aspen RxHealth, raised $23.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace David Medvedeff

David Medvedeff

CEO

imagePlace Leah Carden

Leah Carden

CFO

imagePlace Clayton Walberg

Clayton Walberg

Chief Commercial Officer

imagePlace Wuhong Li

Wuhong Li

Co-founder

Funding Rounds

Funding rounds

4

Investors

7

Lead Investors

0

Total Funding Amount

$35.0M

Details

3

Aspen RxHealth has raised a total of $35.0M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2018Seed3.0M
2018Early Stage Venture9.0M
2021Early Stage Venture23.0M

Investors

Aspen RxHealth is funded by 14 investors.

Investor NameLead InvestorFunding RoundPartners
Novartis-FUNDING ROUND - Novartis23.0M
McKesson Ventures-FUNDING ROUND - McKesson Ventures23.0M
Aspen RxHealth-FUNDING ROUND - Aspen RxHealth23.0M
dRx Capital-FUNDING ROUND - dRx Capital23.0M

Recent Activity

There is no recent news or activity for this profile.